Literature DB >> 22301147

Induced pluripotent stem cell clones reprogrammed via recombinant adeno-associated virus-mediated transduction contain integrated vector sequences.

J Weltner1, A Anisimov, K Alitalo, T Otonkoski, R Trokovic.   

Abstract

Fibroblasts can be reprogrammed into induced pluripotent stem cells (iPSC) by ectopic expression of key transcription factors. Current methods for the generation of integration-free iPSC are limited by the low efficiency of iPSC generation and by challenges in reprogramming methodology. Recombinant adeno-associated virus (rAAV) is a potent gene delivery vehicle capable of efficient transduction of transgenic DNA into cells. rAAV stays mainly as an episome in nondividing cells, and the extent of integration is still poorly defined for various replicating cells. In this study, we aimed to induce iPSC from mouse and human fibroblasts by using rAAV vector-mediated transient delivery of reprogramming factors. We succeeded in deriving induced pluripotent stem cells from mouse but not human fibroblasts. Unexpectedly, the rAAV vector-mediated reprogramming led to frequent genomic integration of vector sequences during the reprogramming process, independent of the amount of virus used, and to persistent expression of reprogramming factors in generated iPSC clones. It thus appears that rAAV vectors are not compatible with the derivation of integration-free iPSC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301147      PMCID: PMC3318626          DOI: 10.1128/JVI.06302-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Recombinant adeno-associated virus-based vectors provide short-term rather than long-term transduction of primitive hematopoietic stem cells.

Authors:  R van Os; H Avraham; N Banu; P M Mauch; J Whater; Y Yang; B Du
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

2.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome.

Authors:  R T Surosky; M Urabe; S G Godwin; S A McQuiston; G J Kurtzman; K Ozawa; G Natsoulis
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Novel tools for production and purification of recombinant adenoassociated virus vectors.

Authors:  D Grimm; A Kern; K Rittner; J A Kleinschmidt
Journal:  Hum Gene Ther       Date:  1998-12-10       Impact factor: 5.695

Review 5.  Adeno-associated viral vectors as gene delivery vehicles.

Authors:  P J Carter; R J Samulski
Journal:  Int J Mol Med       Date:  2000-07       Impact factor: 4.101

6.  Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice.

Authors:  Johanna Jalkanen; Pia Leppänen; Katri Pajusola; Outi Närvänen; Anssi Mähönen; Elisa Vähäkangas; David R Greaves; Hansruedi Büeler; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2003-12       Impact factor: 11.454

7.  AAV serotype 2 vectors preferentially integrate into active genes in mice.

Authors:  Hiroyuki Nakai; Eugenio Montini; Sally Fuess; Theresa A Storm; Markus Grompe; Mark A Kay
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

8.  The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication.

Authors:  Rachel A Schwartz; Jose Alejandro Palacios; Geoffrey D Cassell; Sarah Adam; Mauro Giacca; Matthew D Weitzman
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

9.  Adeno-associated virus vectors integrate at chromosome breakage sites.

Authors:  Daniel G Miller; Lisa M Petek; David W Russell
Journal:  Nat Genet       Date:  2004-06-20       Impact factor: 38.330

10.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

View more
  10 in total

1.  Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.

Authors:  Mong-Jen Chen; Yuanqing Lu; Takashi Hamazaki; Hsin-Yin Tsai; Kirsten Erger; Thomas Conlon; Ahmed S Elshikha; Hong Li; Arun Srivastava; Chunli Yao; Mark Brantly; Vince Chiodo; William Hauswirth; Naohiro Terada; Sihong Song
Journal:  Hum Gene Ther Methods       Date:  2013-12-28       Impact factor: 2.396

2.  Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.

Authors:  Ras Trokovic; Jere Weltner; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Veikko Salomaa; Anu Jalanko; Timo Otonkoski; Aija Kyttälä
Journal:  Stem Cells Transl Med       Date:  2014-10-29       Impact factor: 6.940

3.  The Evolution of Stem Cells, Disease Modeling, and Drug Discovery for Neurological Disorders.

Authors:  Cameron Pernia; Brian T D Tobe; Ryan O'Donnell; Evan Y Snyder
Journal:  Stem Cells Dev       Date:  2020-05-06       Impact factor: 3.272

Review 4.  Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave.

Authors:  Brenna Sharp; Ramya Rallabandi; Patricia Devaux
Journal:  Mol Diagn Ther       Date:  2022-06-28       Impact factor: 4.476

Review 5.  Concise review: drug discovery in the age of the induced pluripotent stem cell.

Authors:  Huaising C Ko; Bruce D Gelb
Journal:  Stem Cells Transl Med       Date:  2014-02-03       Impact factor: 6.940

6.  Derivation of Induced Pluripotent Stem Cells from Human Fibroblasts Using a Non-integrative System in Feeder-free Conditions.

Authors:  Alvaro A Beltran; Sarahi G Molina; Adriana S Beltran
Journal:  Bio Protoc       Date:  2020-10-20

7.  AAVvector-mediated in vivo reprogramming into pluripotency.

Authors:  Elena Senís; Lluc Mosteiro; Stefan Wilkening; Ellen Wiedtke; Ali Nowrouzi; Saira Afzal; Raffaele Fronza; Henrik Landerer; Maria Abad; Dominik Niopek; Manfred Schmidt; Manuel Serrano; Dirk Grimm
Journal:  Nat Commun       Date:  2018-07-09       Impact factor: 14.919

8.  Improving therapeutic potential of non-viral minimized DNA vectors.

Authors:  Lirio M Arévalo-Soliz; Cinnamon L Hardee; Jonathan M Fogg; Nathan R Corman; Cameron Noorbakhsh; Lynn Zechiedrich
Journal:  Cell Gene Ther Insights       Date:  2020-11-19

9.  High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.

Authors:  Liujiang Song; Xiaomiao Li; Giridhara R Jayandharan; Yuan Wang; George V Aslanidi; Chen Ling; Li Zhong; Guangping Gao; Mervin C Yoder; Changquan Ling; Mengqun Tan; Arun Srivastava
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  Non-Human Primate iPSC Generation, Cultivation, and Cardiac Differentiation under Chemically Defined Conditions.

Authors:  Michael Stauske; Ignacio Rodriguez Polo; Wadim Haas; Debbra Yasemin Knorr; Thomas Borchert; Katrin Streckfuss-Bömeke; Ralf Dressel; Iris Bartels; Malte Tiburcy; Wolfram-Hubertus Zimmermann; Rüdiger Behr
Journal:  Cells       Date:  2020-05-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.